Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195
Kazuhisa Tsuchida(Hokkaido University), Takayoshi Koike(Hokkaido University), Hideaki Miyoshi(United States Department of Agriculture), Shintaro Ishikawa(Otsuka (Japan)), Masatoshi Ishida(Hokkaido University), KOICHI YASUMURA(Otsuka (Japan)), Tatsuya Atsumi(Hokkaido University), Zenji Makita, Singo OBARA(Hokkaido University), Sho‐ichi Yamagishi(Kurume University)
Cited by 214
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Nitrogen and phosphorus constrain the CO2 fertilization of global plant biomass
|Nature Climate Change|2019|528
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
|Annals of the Rheumatic Diseases|2007|413